Retention is a Revenue Strategy
The Case for Recovery Engagement in OTP & StUD Programs
March 12, 2026
The Revenue Case: What Engagement Is Actually Worth
The financial case for comprehensive recovery engagement starts with the cost of losing a patient. Roughly 30% of participants drop out of in-person SUD treatment, and the revenue impact of each lost patient ranges from $2,325 to $21,404 per treatment episode. Beyond direct revenue loss, high churn creates compounding costs: administrative burden from re-engagement work, weakened quality scores affecting future contracts, and an unstable census that makes operations harder to manage. The financial value of a retained patient, by contrast, compounds over time.
Learn how digital tools can improve patient retention!
For OTPs: Maximizing the Bundle
Opioid Treatment Programs (OTPs) operate under a weekly bundled payment intended to cover the full range of required services. The structural challenge is that the national average Medicaid bundled rate is only 56% of the Medicare rate for methadone treatment, yet patient-level data consistently reflects a Medicaid-dominant payer mix; BayMark Health, one of the largest OTP networks in the country, reports approximately 75% of its patients are Medicaid beneficiaries, and California’s DHCS reported 81% of OTP patients statewide identified Medicaid as their primary payer in 2022. In this environment, comprehensive engagement is a margin strategy. Programs that consistently deliver the full scope of bundled services maximize revenue from each weekly payment. Programs that don’t are leaving reimbursed services undelivered while absorbing the same overhead.
For StUD Programs: Engagement Is the Revenue Model
With no FDA-approved medications for stimulant use disorder, StUD programs depend entirely on behavioral interventions and are reimbursed primarily through Medicaid fee-for-service billing – individual counseling, group therapy, case management, and peer support billed per contact via Medicaid H-codes. Medicaid is the single largest payer for SUD treatment in the United States. A patient attending twice-weekly group and weekly individual counseling generates significantly more billable activity than one who attends sporadically. Engagement density is the business model. StUD programs also draw heavily on SAMHSA grant funding – SOR, TOR and SUBG grants support contingency management, peer support, and behavioral programming – and a recovery engagement infrastructure positions programs to deploy these funds effectively and sustain them.
Quality Metrics: An Emerging Revenue Lever for Both
HEDIS measures, state quality incentive programs, and value-based contracting increasingly tie revenue to outcomes: retention rates, counseling attendance, medication adherence, and timely follow-up. Programs with strong engagement infrastructure, and the data to demonstrate it, are positioned to capture quality bonuses and secure favorable contract terms. Those without it face a compounding disadvantage: poor retention produces poor metrics, which constrain the resources available to improve care.
For OTPs, comprehensive recovery engagement maximizes constrained bundled payments and quality incentives. For StUD programs, it directly drives fee-for-service revenue and grant performance. In both cases, retention is the foundation, and engagement is what drives retention.
The Clinical Case: Evidence and the Engagement Gap
Patients retained in treatment face dramatically lower mortality – all-cause mortality is more than three times higher when patients leave methadone treatment compared to while they are in it. The steepest drop-offs occur at three and six months – the same window when most programs’ engagement intensity also tends to decline. What happens during those gaps matters enormously.
What Happens Between Appointments
Consider the recovery week for a typical patient: one clinic visit, and perhaps two group visits. For the remaining 160+ hours, they navigate recovery independently – managing triggers, handling stress, facing moments of craving or crisis. When something happens at 9pm on a Tuesday, their options are limited to a crisis line staffed by people who don’t know their history, an ED that won’t contextualize the moment within their treatment plan or choosing to get through it alone. Whatever the outcome, it rarely surfaces in the next appointment and is rarely integrated into their care.
This structural gap – the time between when care is delivered and when patients actually need it – is one of the strongest drivers of dropout. Comprehensive engagement closes it: 24/7 peer support from people who know the patient’s goals, digital tools for working through triggers in real time, care team communication channels, and early warning systems that flag risk before disengagement. When something does happen between visits, it becomes part of the clinical record rather than invisible to it.
Contingency Management: The Strongest Evidence
For StUD programs, recovery rewards or contingency management (CM), are among the most effective interventions available. A 2025 study in the American Journal of Psychiatry analyzing the full VHA database found veterans with stimulant use disorder who received CM had a 41% lower risk of death compared to matched controls. A 2021 meta-analysis in JAMA Psychiatry of 74 randomized trials and 10,000+ adults found CM significantly improved abstinence, treatment attendance, and medication adherence.
Real-world results reflect the research. Sun River Health reported a 98% retention rate among patients in a digital CM program, compared to 86% for those not participating. SAMHSA recommends CM for stimulant use disorder and, under 2025 guidelines, grant recipients may provide incentives up to $750 per patient per year. For OTPs, CM alongside MOUD improves medication adherence and reduces concurrent substance use.
CBT and Peer Support: Reinforcing Recovery Between Visits
Between-visit CBT reinforcement, worksheets, skill reviews, and trigger tracking via digital tools extends the therapeutic relationship into the hours where recovery is most tested. For OTPs required by regulation to deliver behavioral health services within the bundle, this also fulfills compliance requirements while generating the engagement that drives retention. Peer recovery support complements both: SAMHSA’s 2024 guidance highlights peer services as a meaningful clinical complement, and SOR, TOR, SUBG grants, and opioid settlement dollars can fund them. Between-visit isolation is one of the most common and preventable pathways out of treatment.
What keeps patients in treatment is continuous, multi-channel recovery engagement — not the intensity of any single intervention. Comprehensive programs built on this principle can outperform episodic models both clinically and financially.
The Scale Case: More Patients, Not More Staff
The challenge is sustaining recovery engagement at scale without proportional cost increases. Digital tools address this by acting as force multipliers: extending clinical reach without linearly adding FTEs.
Workforce Economics
When appointment reminders, CM goal tracking, between-session check-ins, and compliance documentation are handled digitally, counselors are freed up to work at the top of their clinical licenses. A counselor spending 30% of their time on coordination tasks is delivering roughly 28 patients’ worth of clinical value while being paid for 40. Digital infrastructure reclaims that capacity and improves the quality of clinical time that remains, because counselors arriving with visibility into a patient’s week are better positioned to address what happened. Staff retention improves too: reduced administrative burden correlates with lower burnout in a field with chronic turnover, where replacing a clinical position costs $10,000 to $30,000.
Hybrid Care and Operational Intelligence
Despite OTP growth, 35% of Medicare beneficiaries still live in counties without access to one. Digital platforms support hybrid models that extend geographic reach without capital investment or regulatory approval timelines, patients access medication dosing or in-person counseling at the clinic, and additional services remotely. For operations, digital platforms turn compliance burden into intelligence: real-time dashboards surfacing retention trends, counseling attendance, medication adherence, and toxicology results enable programs to identify at-risk patients before they leave, not after.
Digital tools don’t replace clinical judgment. They remove the friction that prevents clinical staff from applying it consistently, at scale, to every patient in the program.
The Choice Ahead
More than 100,000 Americans die annually from drug overdose. SAMHSA estimates more than 4 million Americans currently meet criteria for stimulant use disorder alone. The programs built to address this will be tested not just on whether they can deliver good care, but on whether they can do so sustainably, at scale, over years, for populations whose needs are chronic and complex.
Programs built around transactional models – episodic contact, minimal between-visit support, manual operations – are structurally ill-suited to that test. High churn forces constant patient acquisition to maintain census. Underutilized bundled capacity wastes reimbursement. Administrative burden crowds out care. And patients who need support at 9pm on a Tuesday have nowhere to turn within their treatment ecosystem.
Comprehensive recovery engagement programs solve for all of these at once – extending therapeutic contact, leveraging clinical staff more effectively, generating quality-driven revenue, and creating the operational stability that allows programs to grow rather than simply manage attrition. For OTPs, it means using the bundled payment as it was designed: infrastructure for comprehensive care. For StUD programs, it means building engagement density into program design, because density is both the clinical mechanism and the revenue model. For both, digital infrastructure is not an add-on, it is what makes comprehensive care deliverable at scale.
